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Munich has examined the impact of  adding cognitive training to 
aerobic exercise in multi-episode schizophrenia patients. This com-
bination led to increased verbal memory and improved global func-
tioning. Increase in left temporal grey matter volume is a promising 
brain mechanism of  action. Dr. Keith Nuechterlein from UCLA will 
present results from a recently completed RCT of  first-episode schizo-
phrenia patients in which aerobic exercise training was added to com-
puterized cognitive training to determine the extent to which it could 
enhance the impact of  cognitive training. He will show that this com-
bination significantly enhances cognition and work/school function-
ing gains beyond the effect of  cognitive training alone and leads to 
increases in prefrontal cortical thickness and functional connectivity. 
Furthermore, he will examine early BDNF increases in response to 
treatment as a predictor of  later cognitive and functional improve-
ments. Dr. Peter Falkai will lead the discussion of  the promise of  aer-
obic exercise as an intervention to improve physical health, cognition, 
and functional outcome in schizophrenia and consider the potential 
mechanisms of  action.
11.1 EFFECT OF INTERVAL TRAINING 
ON METABOLIC RISK FACTORS IN 
OVERWEIGHT INDIVIDUALS WITH PSYCHOSIS: 
A RANDOMIZED CONTROLLED TRIAL
Ahmed Jérôme Romain1, Cédine Fankam1, Antony Karelis2, 
Elaine Letendre3, Gladys Mikolajacks1, Emmanuel Stip1, 
Amal Abdel-Baki*,3
1University of Montreal Hospital Research Centre; 2University of 
Quebec at Montreal; 3University Hospital of Montreal
Background: Among adults with psychotic disorders, negative symptoms 
as unhealthy lifestyle habits contribute to a high prevalence of metabolic 
syndrome and obesity. Lifestyle interventions, mainly physical activity (PA) 
has emerged as an essential component. Furthermore, interval training (IT) 
was found to be efficacious in other populations but poorly studied among 
people with psychosis.
The objective was to determine the effects of a 6-month IT program on 
metabolic, anthropometric, and psychiatric/functional outcomes.
Methods: Randomized controlled trial comparing the effects of a bi-weekly 
30 minutes supervised IT program to a waiting list of overweight individu-
als with psychosis. Body composition and metabolic risk factors (blood 
pressure, insulin resistance, lipid profile) were measured at baseline and 
every 3 months. The groups were compared on an intent to treat basis with 
repeated-measures mixed linear models with the restricted maximum of 
likelihood method of estimation.
Results: Sixty-seven individuals (28 control: waiting list; 39 IT interven-
tion) with psychosis (60.6% men, mean age: 31.0  ±  7.2  years old; BMI: 
32.0 ± 6.1 kg/m2, waist circumference: 107.7 ± 13.3 cm) were included in 
the study, and 67.2% completed the study. Attendance for the IT sessions 
was 61.8% and the dropout rate was 32%. IT was associated with signifi-
cant improvements on waist circumference (-2.72 cm, SE = 1.34; p = 0.04), 
negative symptoms (-2.93, SE = 1.34; p = 0.03), social (SOFAS) (+5.23, 
SE = 2.39; p = 0.03) and global functioning (+7.34, SE = 2.05; p < 0.001). 
The effects of exercise in the first-episode psychosis (FEP) sub-group were 
similar to those of the entire cohort.
Discussion: These promising results suggest that IT may be used as a 
treatment strategy for the management of  metabolic complications and 
possibly improve social functioning in obese individuals with psychotic 
disorders. Further studies are needed to understand if  IT could prevent 
weight gain and metabolic complications if  used before these comorbidi-
ties emerge and to understand factors associated with the persistence of 
exercising.
11.2 THE IMPACT OF AEROBIC EXERCISE ON 
COGNITIVE FUNCTIONING AND BIOMARKERS 
OF COGNITIVE CHANGE IN INDIVIDUALS 
WITH SCHIZOPHRENIA
David Kimhy*,1, Julia Vakhrusheva2, Matthew Bartels3, 
Jacob Ballon4, Eero Castrén5, Richard Sloan2
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Background: Individuals with schizophrenia (SZ) display substantial cog-
nitive deficits across multiple domains. These deficits have been identified 
as major determinants of poor functioning and disability, representing a 
serious public health concern and an important target for interventions. 
At present, available treatments offer only minimal to limited benefits to 
ameliorate these deficits. Thus, there remains an urgent need to identify 
novel treatments for cognitive deficits in people with SZ. Emerging evidence 
from studies of animals, clinical and non-clinical populations suggest that 
Aerobic Exercise (AE) is efficacious in improving cognition via up-regula-
tion of Brain-Derived Neurotrophic Factor (BDNF). Yet, the impact of 
AE on cognition and daily-functioning, and the role of BDNF, have not 
been investigated in schizophrenia. Additionally, limited information is 
available on the putative link between inflammation markers to cognitive 
functioning.
Methods: Employing a single-blind RCT design, 33 individuals with schiz-
ophrenia were randomized to receive “treatment as usual” (n=17; TAU) 
or attend a 12-week, 3 times-per-week, 60-minutes AE program (n=16) 
utilizing active-play video-games (Xbox-360 Kinect) and traditional AE 
equipment.
Results: At baseline, cognitive functioning was associated with serum 
BDNF (r=.51, p=.01), along with TNF-alpha (r=-.38, p=.03), IL-12 
(r=-.36, p=.04) and IL-6 (r=-.33, p=.06). Twenty-six participants com-
pleted the study (79%). Following the intervention, the AE participants 
improved their cognitive functioning (MCCB) by 15.1% (vs. -2.0% in the 
TAU group; p=.03). Hierarchical multiple-regression analyses indicated 
changes in AF and serum BDNF predicted 25.4% and 14.6% of  the cog-
nitive improvement, respectively. Additionally, changes in aerobic fitness 
(VO2peak ml/kg/min) correlated with informant-reported improvements 
in work-related daily-functioning skills (SLOF; r=.51, p=.01). Fidelity 
with target training intensity, was correlated with cognitive improvement 
(r=.70, p=.02).
Discussion: The results indicate AE is effective in enhancing cognitive 
and daily functioning skills in people with schizophrenia and provide 
support for the impact of  AE-related BDNF up-regulation on cognition. 
Additional studies are needed to establish the link between inflamma-
tion markers and cognitive functioning and the potential impact of  AE 
on this putative pathway. Overall, low aerobic fitness represents a mod-
ifiable risk-factor for cognitive dysfunction in schizophrenia for which 
AE training offer a relatively safe, non-stigmatizing, and side-effect-free 
intervention.
11.3 CLINICAL AND NEUROBIOLOGICAL 
EFFECTS OF A CONTINUOUS AEROBIC 
ENDURANCE TRAINING IN MULTI-EPISODE 
SCHIZOPHRENIA PATIENTS
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Background: Structural and functional brain alterations as well as cognitive 
deficits are well-documented findings in schizophrenia patients. Cognitive 
impairments affect the long-term outcome of schizophrenia and are the 
main contributors to disability. Aerobic endurance training has been shown 
to have effects on brain plasticity, gray and white matter volume as well as 
functional connectivity measures and on cognitive functioning in animal 
models and healthy humans. However, effects of physical exercise in com-
bination in combination with cognitive remediation (CR) are unknown in 
schizophrenia.
Methods: 21 chronic schizophrenia patients and 21 age- and gender-matched 
healthy controls underwent 3 months of aerobic exercise (endurance train-
ing, 30  min, 3 times per week). 21 additionally recruited schizophrenia 
patients played table soccer (known as “foosball” in the USA) over the 
same period. After 6 weeks of endurance training or table soccer, all partici-
pants commenced standardized cognitive training with a computer-assisted 
training program. Clinical symptoms, thorough neuropsychological testing 
and multimodal neuroimaging with 3D-volumetric T1-weighted sequences, 
DTI and magnetic resonance spectroscopy (MRS) were performed on a 
3T MR scanner at baseline and after the 3-month intervention and 3 addi-
tional training-free months. DNA from all subjects was genotyped with the 
Infinium PsychArray Chip (Illumina, San Diego, CA, USA). Polygenic risk 
scores were calculated and associated with hippocampal subfield volume 
change.
Results: In summary, a 3-month endurance training program combined 
with CR therapy for the last 6 weeks of  the intervention period was feasi-
ble (Keller-Varady et al. 2016) and had positive effects on everyday func-
tioning in multi-episode schizophrenia patients. Deficits improved from 
medium to mild as assessed with the GAF. Negative symptoms, short- and 
long-term verbal memory and cognitive flexibility also improved with 
endurance and cognitive training (Malchow et al. 2015). We could dem-
onstrate grey matter volume increase in the left temporal lobe in schiz-
ophrenia patients undergoing endurance training. A non-endurance and 
coordinative training stimulus like playing table soccer led to a clearly dis-
tinct pattern of  grey matter alterations in schizophrenia patients (Malchow 
et al. 2016). There were no effects of  the intervention on structural and 
functional brain networks in schizophrenia patients as well as MRS meas-
ures (in preparation). No effects of  PRSs were found on total hippocam-
pal volume change. Subfield analyses showed that the volume changes 
between baseline and 3  months in the left CA4/DG were significantly 
influenced by PRSs in schizophrenia patients performing aerobic exercise. 
A larger genetic risk burden was associated with a less pronounced volume 
increase or a decrease in volume over the course of  the exercise interven-
tion. Results of  exploratory enrichment analyses reinforced the notion of 
genetic risk factors modulating biological processes tightly related to syn-
aptic ion channel activity, calcium signaling, glutamate signaling and reg-
ulation of  cell morphogenesis (Papiol et al. 2017).
Discussion: Exercise interventions are feasible and effective interventions 
for people with schizophrenia and might also help to disentangle the under-
lying brain pathology of the disorder.
11.4 AEROBIC EXERCISE ENHANCES 
COGNITIVE TRAINING EFFECTS IN FIRST 
EPISODE SCHIZOPHRENIA: COGNITIVE 
AND FUNCTIONAL GAINS AND PROMISING 
BIOLOGICAL MECHANISMS OF ACTION
Keith Nuechterlein*,1, Sarah McEwen1, Joseph Ventura1, 
Kenneth Subotnik1, Luana Turner1, Michael Boucher1,  
Laurie Casaus1, Jacqueline Hayata1
1University of California, Los Angeles
Background: The search for treatments to remediate cognitive deficits and 
their functional outcome consequences remains a critical frontier in schiz-
ophrenia. Cognitive training and aerobic exercise both show promising 
moderate impact on cognition and everyday functioning. Aerobic exercise 
is hypothesized to increase brain-derived neurotrophic factor (BDNF) and 
thereby stimulate neurogenesis and synaptic plasticity, leading to increased 
learning capacity. Systematic cognitive training should take advantage of 
increased learning capacity and be more effective when combined with aer-
obic exercise.
Methods: In a recently completed randomized controlled trial, we exam-
ined the impact of a 6-month program of Cognitive Training & Exercise 
(CT&E) compared to Cognitive Training alone (CT) in 47 first-episode 
schizophrenia outpatients. All participants were provided the same Posit 
Science computerized cognitive training, four hours/week, using BrainHQ 
and SocialVille programs. The CT&E group also participated in total body 
circuit training exercises to enhance aerobic conditioning. The exercise 
intensity was in the 60–80% of aerobic capacity range, combining clinic 
and home-based exercise for a target of 150 minutes per week.
Results: Mixed model analyses demonstrate that the MATRICS Consensus 
Cognitive Battery Overall Composite improves significantly more by 
3  months with CT&E than with CT alone (6.6 vs. 2.2 T-score points, 
p<.02). Work/school functioning improves substantially more with CT&E 
than with CT alone by 6 months (p<.001). BDNF is a promising mechan-
ism of action, improving even after 2 weeks and predicting the amount of 
cognitive gain at 3 months. The magnitude of cognitive gain by 3 months 
predicts the amount of work/school functioning improvement at 6 months, 
suggesting a cascade of effects. Analyses by Dr. McEwen show differ-
ential increases in cortical thickness in the left dorsal lateral prefrontal 
gyrus (p=.02) and right superior frontal gyrus (p=.02) over 6 months and 
increased functional connectivity in the central executive network (p=.04) 
with CT&E compared to CT alone and correlations of these increases with 
cognitive and functional outcome gains.
Discussion: We conclude that aerobic exercise significantly enhances the 
impact of cognitive training on cognition, functional outcome, and frontal 
cortical thickness in first-episode schizophrenia and that BDNF is a prom-
ising mechanism of action for these effects.
12. SYNAPTIC DYSFUNCTION IN 
SCHIZOPHRENIA: EXPLORATION OF NOVEL 
HYPOTHESES AND PROMISING NEW LEADS
Laura Rowland
University of Maryland School of Medicine
Overall Abstract: Accumulating evidence suggests that bioenergetic func-
tion is impaired in the brain in schizophrenia. In normal brain, glucose is 
metabolized to lactate and pyruvate, which are monocarboxylate interme-
diates that serve as the primary energy source for neurons. Working mem-
ory and other cognitive domains are dependent on the shuttling of lactate 
from astrocytes to neurons. Defects in this complex pathway may underlie 
cognitive dysfunction in schizophrenia. The focus of this symposium is to 
present evidence of such defects, and to identify substrates that may be tar-
geted for the development of new treatment strategies. Dr. Laura Rowland 
(University of Maryland, Baltimore, Maryland, USA) will present evi-
dence of bioenergetic dysfunction in living subjects with schizophrenia. 
Increased levels of lactate (P < 0.05) were present in the ACC in schizophre-
nia (n = 27) compared to controls (n = 29). Higher lactate levels were asso-
ciated with lowers scores on the MATRICS Consensus Cognitive Battery. 
These data establish a direct link between cognition and bioenergetic func-
tion in vivo in schizophrenia. Dr. Robert McCullumsmith (University of 
Cincinnati, Cincinnati, Ohio, USA) will present evidence of alterations 
in the lactate shuttle and glycolytic enzymes in postmortem samples from 
schizophrenia (n  =  20) and control subjects (n  =  20). Cell-subtype spe-
cific changes (P < 0.05) in transcripts include increased levels of the lac-
tate transporter MCT4, decreased levels of the glycolytic enzymes PFK1 
and hexokinase, and decreased levels of the glucose transporters Glut1 
and Glut3. These data suggest attenuated glycolysis in pyramidal neurons, 
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